MedPath
NMPA Approval

Midazolam Injection

国药准字H20243613

April 24, 2024

Drug Information

咪达唑仑注射液

注射剂

5ml:5mg(按C₁₈H₁₃ClFN₃计)

化学药品

April 24, 2024

Company Information

Applicant Company

重庆市渝北区黄杨路2号

Manufacturing Company

重庆市渝北区黄杨路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

咪达唑仑注射液 - NMPA 批准文号 | MedPath